Related Experiment Videos
Summary
Patients with acute promyelocytic leukemia (APL) and disseminated intravascular coagulation (DIC) show significant thrombin generation. Prothrombin fragment F1 + 2 may be a more sensitive indicator of DIC than fibrinopeptide A.
Area of Science:
- Hematology
- Oncology
- Clinical Chemistry
Background:
- Disseminated intravascular coagulation (DIC) is a serious condition often associated with acute promyelocytic leukemia (APL).
- Quantifying thrombin generation is crucial for understanding hemostatic system hyperactivity in leukemia patients.
Purpose of the Study:
- To investigate and compare thrombin generation levels in patients with APL and other forms of acute nonlymphocytic leukemia (ANLL).
- To evaluate the utility of prothrombin activation fragment F1 + 2 and thrombin-antithrombin complex (TAT) as markers for DIC in these patient groups.
Main Methods:
- Sensitive radioimmunoassays were used to measure plasma levels of F1 + 2, TAT, and fibrinopeptide A (FPA).
- Serial measurements were performed during induction chemotherapy in APL patients.
- Correlations between markers were analyzed, particularly in relation to heparin use.
Main Results:
- Both APL and ANLL patients exhibited elevated levels of F1 + 2, TAT, and FPA at presentation.
- Thrombin generation markers were significantly higher and showed a stronger correlation between TAT and FPA in APL compared to ANLL.
- Antileukemic therapy sometimes led to increased plasma levels of these markers.
Conclusions:
- Patients with APL and ANLL generate excessive thrombin, confirming DIC.
- Prothrombin fragment F1 + 2 appears to be a more sensitive indicator of hemostatic system hyperactivity in DIC than FPA.